Literature DB >> 21769732

The reliability of the intermittent critical velocity test and assessment of critical rest interval in men and women.

David H Fukuda1, Abbie E Smith, Kristina L Kendall, Robert P Hetrick, Ryan L Hames, Joel T Cramer, Jeffrey R Stout.   

Abstract

The purpose of this study was to examine the reliability of the intermittent critical velocity (ICV) test and assess critical rest interval (CRI) during repeated-sprint exercise. The ICV test is used to examine the linear relationship between total distance and time-to-exhaustion during interval exercise, yielding a repeatable, moderate-intensity parameter (ICV), a high-intensity exhaustive parameter (W'), and CRI. CRI is the theoretical rest period needed to complete a series of repeated bouts of exercise without fatigue. Twenty-four healthy college-aged men (mean ± SD; age 22.7 ± 2.9 years; weight 85.8 ± 15.3 kg; VO(2max) 50.7 ± 8.8 ml/kg/min) and women (mean ± SD; age 21.4 ± 2.3 years; weight 58.9 ± 5.2 kg; VO(2max) 46.4 ± 4.4 ml/kg/min) participants completed two ICV tests (T1 and T2), using 10 s repeated sprints to exhaustion during separate sessions of treadmill running. Linear regression was used to determine ICV and W', while CRI was calculated using the relationship between the number of intervals completed and a variant of ICV. Intraclass correlation coefficients (ICCs) for ICV, W', and CRI were 0.89 (T1 4.42 ± 0.55 m/s; T2 4.34 ± 0.67 m/s), 0.80 (T1 125.6 ± 62.7 m; T2 144.6 ± 65.4 m), and 0.59 (T1 23.9 ± 2.0 s; T2 24.5 ± 2.6 s), respectively. These moderate to high ICC values indicate reliable measurements between ICV trials. Additionally, the evaluation of CRI demonstrated the attainment of a steady-state heart rate (94% of maximum) during a separate session of repeated supramaximal treadmill sprints. The ICV test during treadmill running provides reliable ICV and W' measures, as well as an estimated recovery time via CRI for men and women.

Entities:  

Mesh:

Year:  2011        PMID: 21769732     DOI: 10.1007/s00421-011-2076-z

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  36 in total

1.  Changes in neutrophil surface receptor expression, degranulation, and respiratory burst activity after moderate- and high-intensity exercise.

Authors:  Jonathan Peake; Gary Wilson; Matthew Hordern; Katsuhiko Suzuki; Kanemitsu Yamaya; Kazunori Nosaka; Laurel Mackinnon; Jeff S Coombes
Journal:  J Appl Physiol (1985)       Date:  2004-04-09

2.  Faster oxygen uptake kinetics during recovery is related to better repeated sprinting ability.

Authors:  Gregory Dupont; Alan McCall; Fabrice Prieur; Grégoire P Millet; Serge Berthoin
Journal:  Eur J Appl Physiol       Date:  2010-06-24       Impact factor: 3.078

3.  Muscle and blood metabolites during a soccer game: implications for sprint performance.

Authors:  Peter Krustrup; Magni Mohr; Adam Steensberg; Jesper Bencke; Michael Kjaer; Jens Bangsbo
Journal:  Med Sci Sports Exerc       Date:  2006-06       Impact factor: 5.411

4.  Predicting intermittent running performance: critical velocity versus endurance index.

Authors:  M Buchheit; P B Laursen; G P Millet; F Pactat; S Ahmaidi
Journal:  Int J Sports Med       Date:  2007-09-18       Impact factor: 3.118

Review 5.  Critical power: implications for determination of V˙O2max and exercise tolerance.

Authors:  Andrew M Jones; Anni Vanhatalo; Mark Burnley; R Hugh Morton; David C Poole
Journal:  Med Sci Sports Exerc       Date:  2010-10       Impact factor: 5.411

6.  Critical velocity of continuous and intermittent running exercise. An example of the limits of the critical power concept.

Authors:  M Kachouri; H Vandewalle; V Billat; M Huet; M Thomaïdis; E Jousselin; H Monod
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1996

7.  Critical velocity during continuous and intermittent exercises in children.

Authors:  Serge Berthoin; Georges Baquet; Gregory Dupont; Emmanuel Van Praagh
Journal:  Eur J Appl Physiol       Date:  2006-08-17       Impact factor: 3.078

8.  Adipose tissue extracts plasma ammonia after sprint exercise in women and men.

Authors:  Mona Esbjörnsson; Jens Bülow; Barbara Norman; Lene Simonsen; Jacek Nowak; Olav Rooyackers; Lennart Kaijser; Eva Jansson
Journal:  J Appl Physiol (1985)       Date:  2005-11-10

9.  The maximally attainable VO2 during exercise in humans: the peak vs. maximum issue.

Authors:  J R Day; H B Rossiter; E M Coats; A Skasick; B J Whipp
Journal:  J Appl Physiol (1985)       Date:  2003-07-11

10.  Sex difference in maximal oxygen uptake. Effect of equating haemoglobin concentration.

Authors:  K Cureton; P Bishop; P Hutchinson; H Newland; S Vickery; L Zwiren
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986
View more
  4 in total

1.  Critical velocity and anaerobic paddling capacity determined by different mathematical models and number of predictive trials in canoe slalom.

Authors:  Leonardo H D Messias; Homero G Ferrari; Ivan G M Reis; Pedro P M Scariot; Fúlvia B Manchado-Gobatto
Journal:  J Sports Sci Med       Date:  2015-03-01       Impact factor: 2.988

2.  Fast-start strategy increases the time spent above 95 %VO2max during severe-intensity intermittent running exercise.

Authors:  Rafael Alves de Aguiar; Tiago Turnes; Rogério Santos de Oliveira Cruz; Fabrizio Caputo
Journal:  Eur J Appl Physiol       Date:  2012-10-02       Impact factor: 3.078

3.  Effects of Caffeine on Exercise Duration, Critical Velocity, and Ratings of Perceived Exertion During Repeated-Sprint Exercise in Physically Active Men.

Authors:  Jesse A Stein; Heath G Gasier; Blake D Goodman; Melitza R Ramirez; Blanca P Delatorre; Cassandra M Beattie; Thomas J Barstow; Katie M Heinrich
Journal:  Int J Exerc Sci       Date:  2021-04-01

4.  Ingesting a pre-workout supplement containing caffeine, B-vitamins, amino acids, creatine, and beta-alanine before exercise delays fatigue while improving reaction time and muscular endurance.

Authors:  Brandon D Spradley; Kristy R Crowley; Chih-Yin Tai; Kristina L Kendall; David H Fukuda; Enrico N Esposito; Sarah E Moon; Jordan R Moon
Journal:  Nutr Metab (Lond)       Date:  2012-03-30       Impact factor: 4.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.